Risk factors

Rani Therapeutics Holdings (RANI) risk factors

Item 1A of every Rani Therapeutics Holdings, Inc. 10-K on file, and what changed from one year to the next.

Open RANI in Gloomberb →
  • FY2025 10-K risk factors

    109 risks, 8 new, 18 dropped, 11 reworded since the prior year. Rani Therapeutics highlights new partnership risks with Chugai, NASDAQ listing compliance concerns, and international trade tariff uncertainties.

    Filed Mar 26, 2026
  • FY2024 10-K risk factors

    119 risks. Rani Therapeutics faces substantial going concern risks requiring immediate additional capital to sustain operations and avoid liquidation. The company relies heavily on the unproven RaniPill platform and biologic-device combination products. Strict regulatory hurdles and ongoing clinical trials dictate commercial feasibility.

    Filed Mar 31, 2025